MRM Health
PrivateLast Round
Grant
May 28, 2026
Total Funding Raised
$82.16M
Company Overview
MRM Health operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a Grant round in May 2026.
MRM Health is a clinical-stage biopharmaceutical company that develops innovative microbiome-based live biotherapeutic products for the treatment of chronic inflammatory diseases and immune-oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MRM Health Comparables
Compare MRM Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaBiome | 84% | |
| Vedanta Biosciences | 83% | |
| Microbiotica | 82% |
For institutional investors. Book with your work email.
MRM Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 28, 2026 | ||||
| Series B | Sep 4, 2025 | ||||
| Series A | Feb 19, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MRM Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series B |
| Ackermans & van Haaren | Series B, Series A |
| Athos KG | Series B |
| Qbic II | Series A, Series B |
| BNP Paribas Fortis Private Equity | Series B |
| Biocodex | Series B |
| VIB | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
IND clearance granted for Phase 2b trial of MH002 for ulcerative colitis.
- Jan 5, 2026
Presenting at Digestive Disease Week (DDW) 2026 in Chicago.
For institutional investors. Book with your work email.
MRM Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MRM Health's valuation, stock price, and market status.
Is MRM Health a public or private company?
MRM Health is a private company.
What is the current stock price of MRM Health?
MRM Health is a private company, so its shares have no public market price. Caplight tracks MRM Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MRM Health worth (valuation)?
Valuation information for MRM Health is not publicly available.
Can I buy MRM Health stock?
MRM Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MRM Health's last funding round?
MRM Health's most recent funding round was Grant on May 28, 2026.
Who are the main investors in MRM Health?
Key investors in MRM Health include Ackermans & van Haaren, Biocodex.
Will MRM Health IPO soon?
No public IPO plans have been announced for MRM Health.
How can I track MRM Health secondary market activity?
Caplight tracks bids, offers, and trades in MRM Health's shares on secondary markets.